Windtree Therapeutics Inc Asset Resilience Ratio

Latest as of December 2019: 0.00%

Windtree Therapeutics Inc asset resilience ratio. Windtree Therapeutics Inc (WINT) has an Asset Resilience Ratio of 0.00% as of December 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Windtree Therapeutics Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$0.00

Cash + Short-term Investments

Total Assets

$118.97 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Windtree Therapeutics Inc (1996–2019)

Asset resilience ratio of Windtree Therapeutics Inc from 1996 to 2019. This chart shows how Windtree Therapeutics Inc's Asset Resilience Ratio has changed over time. Read WINT total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Windtree Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see WINT current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$0.00	0%
Total Liquid Assets	$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Windtree Therapeutics Inc maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Windtree Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Windtree Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

Windtree Therapeutics Inc Asset Resilience Ratio by Year (1996–2019)

Windtree Therapeutics Inc asset resilience ratio by year from 1996 to 2019. The table below shows the annual Asset Resilience Ratio data for Windtree Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2019-12-31	0.00%	$0.00	$118.97 Million	--
2018-12-31	11.69%	$13.96 Million	$119.40 Million	+5.46pp
2008-12-31	6.23%	$2.05 Million	$32.89 Million	-19.40pp
2007-12-31	25.62%	$16.08 Million	$62.74 Million	+23.21pp
2006-12-31	2.41%	$829.00K	$34.40 Million	-3.39pp
2005-12-31	5.80%	$3.25 Million	$56.01 Million	-1.49pp
2004-12-31	7.29%	$2.74 Million	$37.64 Million	-43.28pp
2002-12-31	50.57%	$10.65 Million	$21.06 Million	-13.91pp
2001-12-31	64.48%	$12.94 Million	$20.07 Million	+5.71pp
2000-12-31	58.77%	$11.59 Million	$19.72 Million	+4.79pp
1999-12-31	53.97%	$2.50 Million	$4.63 Million	-0.38pp
1998-12-31	54.35%	$2.50 Million	$4.60 Million	+11.61pp
1997-12-31	42.74%	$5.00 Million	$11.70 Million	-36.21pp
1996-12-31	78.95%	$1.50 Million	$1.90 Million	--

pp = percentage points

About Windtree Therapeutics Inc

NASDAQ:WINT USA Biotechnology

Market Cap

$6.74K

Market Cap Rank

#31900 Global

#6425 in USA

Share Price

$0.00

Change (1 day)

-33.33%

52-Week Range

$0.00 - $0.08

All Time High

$366659.31